6505--Buprenorphine Award

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

NAC PHARMACEUTICALS (36E797)

Contract Value

Not provided

Codes & Classification
Solicitation Number

36E79726R0004

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Classification Code

6505

Additional Details
Set Aside

None

Place of Performance

-

SourceSAM
Documents1
The Department of Veterans Affairs (VA), through its National Acquisition Center (NAC) Pharmaceuticals office, has issued an award notice for the procurement of Buprenorphine, as indicated by procurement identifier 36E79726R0004. This contract falls under the North American Industry Classification System (NAICS) code 325412, which pertains to Pharmaceutical Preparation Manufacturing, and is further classified under Product Service Code (PSC) 6505, denoting Drugs and Biologicals. The notice, currently active and posted on July 5, 2026, reflects the VA’s ongoing commitment to securing essential pharmaceutical products for its healthcare system. The primary objective of this procurement is to ensure a reliable supply of Buprenorphine, a critical medication used in the treatment of opioid use disorder and pain management, for distribution across VA medical facilities. The scope of the contract encompasses the manufacturing and delivery of pharmaceutical-grade Buprenorphine, adhering to stringent federal quality and safety standards. The intended outcome is to support the VA’s mission of providing high-quality, evidence-based care to veterans, particularly those affected by substance use disorders. Key requirements for this contract include the ability to manufacture Buprenorphine in compliance with all applicable regulatory guidelines, including those set forth by the Food and Drug Administration (FDA) and the Drug Enforcement Administration (DEA). Contractors must demonstrate robust quality assurance processes, reliable production capacity, and the capability to meet the VA’s distribution and delivery schedules. The awarded contractor is expected to provide consistent product availability, maintain rigorous documentation, and ensure traceability throughout the supply chain. The contracting activity is managed by the NAC Pharmaceuticals office, a federal entity within the Department of Veterans Affairs. The primary point of contact for this procurement is Amber Zavala, who can be reached via email at [email protected] or by phone at (708) 786-5245. Interested parties can access further details and official documentation through the SAM.gov opportunity portal using the Opportunity ID ce7c2c2b630043ceb9f6f8a0666dbcb3. This procurement is classified as an award notice, indicating that the contract has already been awarded and is not currently open for new bids. There is no information provided regarding set-aside requirements or special considerations such as small business preferences or socioeconomic program participation. Contractors evaluating similar opportunities should note the VA’s emphasis on regulatory compliance, product quality, and supply reliability as enduring priorities throughout the contract lifecycle. The procurement supports the VA’s broader healthcare objectives and underscores the importance of partnering with manufacturers capable of meeting the unique needs of the veteran population.